For many clinical research staff members, recruiting participants for a study poses a challenge – sometimes a bigger challenge than conducting the actual trial itself. Delays in recruiting participants will by default extend the study’s timeline, ultimately delaying the treatment’s arrival on the market at the end of the trial.
What are the changes we need to consider to engage a diverse group of patients of all ages and stages and then keep them engaged for the entire trial? Social media has become a key tool but there isn’t just one place to post. What are some of the methodologies that work best? Our first topic will explore how social media should be targeted to the right demographic, especially age.
Our second session will address the lack of diversity in many trials, as well as the patient burden and techniques that are being explored to bring the trial to the patient and help patients to choose their own journey.
Our last session will discuss some of the approaches that are being used to keep the patients engaged and involved because if the trial isn’t completed and the patient drops or is lost to follow-up, the ultimate value of the product’s development is impacted. Keeping patients engaged until the end of their participation is critical, and we will explore how research sites and technology can support that goal.
Erica Rivas - Director of Patient Engagement - Accel Research Sites Network
Kyle Hogan - President - Datacubed Health
- Describe why modern clinical trials doesn’t always mean ‘better for the patient’ and how dropout is an indicator
- Learn how dropout often results when a trial isn’t designed with the patient from the onset
- Build retention strategies throughout the entire clinical trial that generates trust and appreciation from the patients